Maxpil (Finasteride)

Finasteride selectively blocks the type II 5‑alpha‑reductase enzyme, preventing the conversion of testosterone into dihydrotestosterone (DHT). Lower DHT concentrations in the scalp limit hair‑follicle miniaturisation, while reduced DHT in the prostate decreases glandular growth, alleviating BPH symptoms.

The exact dose of Maxpil is determined by the prescribing clinician based on the individual’s condition, age, and response to therapy. Typical regimens for hair loss and BPH are well‑established, but only a qualified health professional can set the appropriate dosage for each patient.

Finasteride is classified as Pregnancy Category X, meaning it is contraindicated in women who are pregnant or may become pregnant because of the risk of fetal harm. It is also not recommended during breastfeeding, as the drug can be excreted in breast milk and affect the infant.

To request Maxpil, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and the necessary import documentation.

The primary alternative to finasteride is dutasteride, another 5‑alpha‑reductase inhibitor that blocks both type I and type II isoenzymes. Dutasteride may achieve a greater reduction in DHT but can have a higher incidence of sexual side effects. Choice between the two depends on clinical judgment, patient tolerance and regulatory approvals.

Store Maxpil at ambient temperature, preferably below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat sources. Ensure the container is tightly closed to maintain tablet integrity until the expiration date.

Maxpil is taken orally, usually with or without food, as directed by the prescriber. The tablet should be swallowed whole with a glass of water and not chewed or crushed, unless a healthcare professional advises otherwise.

Serious adverse events, although rare, include severe allergic reactions (anaphylaxis), breast cancer, and marked depression or suicidal thoughts. Patients should seek immediate medical attention if they notice swelling, rash, breast changes, persistent mood disturbances, or any signs of an allergic response.

Maxpil is contraindicated in women, especially those who are pregnant or may become pregnant, and in children or adolescents. Men with known hypersensitivity to finasteride or other 5‑alpha‑reductase inhibitors should also avoid the product. Individuals with severe liver disease should use it only under close medical supervision.